Market Cap 285.68M
Revenue (ttm) 92.39M
Net Income (ttm) -37.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -40.82%
Debt to Equity Ratio 0.00
Volume 122,200
Avg Vol 223,636
Day's Range N/A - N/A
Shares Out 16.87M
Stochastic %K 9%
Beta 0.26
Analysts Strong Sell
Price Target $31.00

Company Profile

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 852 2210 9588
Address:
Unit 703-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong
Boss1239
Boss1239 Jun. 25 at 9:41 PM
$PRE not sure what to think
0 · Reply
ZacksSCR
ZacksSCR Jun. 23 at 8:58 PM
$PRE CEO Danny Yeung discusses Prenetics' transition from a COVID-era diagnostics business to a wellness brand, and management's view of the category's market opportunity in our latest CEO Chat: https://buff.ly/HV4PDZs
0 · Reply
Sidoti
Sidoti Jun. 23 at 11:32 AM
New research this week on @Prenetics $PRE #sidotiresearch Read note: http://dlvr.it/TT9cH2 #investing #smallcap #microcap
0 · Reply
ZacksSCR
ZacksSCR Jun. 10 at 3:12 PM
$PRE Continues to Post Rapid Growth https://buff.ly/VX7WdKG
0 · Reply
MarketBeat
MarketBeat May. 14 at 7:06 PM
https://marketbeat.com/a/8654885/ $PRE Prenetics Global Q1 Earnings Call Highlights
0 · Reply
ZacksSCR
ZacksSCR May. 14 at 4:42 PM
$PRE Continues Astounding Growth, While Expanding Product Line https://buff.ly/UD4qC7E
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 14 at 1:15 PM
$PRE Q1 '26 Earnings Results & Recap Prenetics raised its full-year 2026 IM8 revenue guidance to $190 million to $210 million, up from the prior range of $180 million to $200 million. Prenetics projects Q2 2026 revenue to be $46 million to $48 million.
0 · Reply
focafoca99
focafoca99 May. 14 at 12:24 PM
$PRE installed Brian J. Rosin as Chief Financial Officer of IM8.
0 · Reply
Sidoti
Sidoti May. 13 at 5:30 PM
New research today on @Prenetics $PRE #sidotiresearch Read note: http://dlvr.it/TSWppr #investing #smallcap #microcap
0 · Reply
focafoca99
focafoca99 May. 4 at 1:50 PM
$PRE outlined its complete Bitcoin treasury divestment, selling about 510 BTC.
0 · Reply
Latest News on PRE
Prenetics initiated with a Buy at Benchmark

2026-06-16T10:25:07.000Z - 18 days ago

Prenetics initiated with a Buy at Benchmark


Prenetics Global Earnings release: Q1 2026

Jun 10, 2026, 8:30 AM EDT - 24 days ago

Prenetics Global Earnings release: Q1 2026


Prenetics Global Slides: Q1 2026

Jun 10, 2026, 8:30 AM EDT - 24 days ago

Prenetics Global Slides: Q1 2026


Prenetics Global Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Prenetics Global Earnings Call Transcript: Q1 2026


Prenetics Global Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Prenetics Global Earnings release: Q1 2026


Prenetics Global Slides: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Prenetics Global Slides: Q1 2026


Prenetics Global Registration statement: Registration filing

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Prenetics Global Registration statement: Registration filing


Prenetics’ IM8 enters partnership with Superpower

2026-03-24T15:10:13.000Z - 3 months ago

Prenetics’ IM8 enters partnership with Superpower


Prenetics Global Transcript: The 38th Annual Roth Conference

Mar 23, 2026, 3:00 PM EDT - 3 months ago

Prenetics Global Transcript: The 38th Annual Roth Conference


Prenetics Global Transcript: The 38th Annual Roth Conference

Mar 23, 2026, 11:30 AM EDT - 3 months ago

Prenetics Global Transcript: The 38th Annual Roth Conference


Prenetics initiated with a Buy at Lake Street

2026-03-16T12:46:14.000Z - 3 months ago

Prenetics initiated with a Buy at Lake Street


Prenetics authorizes $40M share repurchase program

2026-03-06T13:12:18.000Z - 4 months ago

Prenetics authorizes $40M share repurchase program


Prenetics announces executive open market share purchases

2026-03-03T13:22:08.000Z - 4 months ago

Prenetics announces executive open market share purchases


Prenetics announces launch of Daily Ultimate Essentials PRO

2026-02-23T14:15:10.000Z - 4 months ago

Prenetics announces launch of Daily Ultimate Essentials PRO


Prenetics Global Earnings Call Transcript: Q4 2025

Feb 18, 2026, 10:00 AM EST - 4 months ago

Prenetics Global Earnings Call Transcript: Q4 2025


Prenetics Global Earnings release: Q4 2025

Feb 18, 2026, 10:00 AM EST - 4 months ago

Prenetics Global Earnings release: Q4 2025


Prenetics Global Slides: Q4 2025

Feb 18, 2026, 10:00 AM EST - 4 months ago

Prenetics Global Slides: Q4 2025


Prenetics Global Annual report: Q4 2025

Feb 18, 2026, 10:00 AM EST - 4 months ago

Prenetics Global Annual report: Q4 2025


Prenetics completes $70M Insighta sale to Tencent

2026-02-18T14:30:25.000Z - 4 months ago

Prenetics completes $70M Insighta sale to Tencent


Prenetics reports Q4 EPS ($1.77)  vs. ($1.01) last year

2026-02-18T14:20:59.000Z - 4 months ago

Prenetics reports Q4 EPS ($1.77) vs. ($1.01) last year


Prenetics completes $70M Insighta Sale to Tencent

2026-02-17T13:21:07.000Z - 4 months ago

Prenetics completes $70M Insighta Sale to Tencent


Prenetics initiated with a Buy at Roth Capital

2026-02-11T10:05:31.000Z - 5 months ago

Prenetics initiated with a Buy at Roth Capital


Prenetics completes sale of its 3PL distribution business

2026-01-06T13:26:48.000Z - 6 months ago

Prenetics completes sale of its 3PL distribution business


Prenetics provides update on voluntary warrant exchange program

2026-01-05T13:11:10.000Z - 6 months ago

Prenetics provides update on voluntary warrant exchange program


Prenetics Announces Upcoming Conference Participation

Nov 25, 2025, 8:49 AM EST - 7 months ago

Prenetics Announces Upcoming Conference Participation


Prenetics Global Earnings Call Transcript: Q3 2025

Nov 10, 2025, 8:30 AM EST - 8 months ago

Prenetics Global Earnings Call Transcript: Q3 2025


Prenetics Global Earnings release: Q3 2025

Nov 10, 2025, 8:30 AM EST - 8 months ago

Prenetics Global Earnings release: Q3 2025


Prenetics Global Registration statement: Registration Filing

Sep 8, 2025, 8:00 AM EDT - 10 months ago

Prenetics Global Registration statement: Registration Filing


Prenetics Global Registration statement: Registration Filing

Aug 22, 2025, 8:00 AM EDT - 11 months ago

Prenetics Global Registration statement: Registration Filing


Prenetics Global Registration statement: Registration Filing

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Prenetics Global Registration statement: Registration Filing


Prenetics Announces Third Quarter 2024 Financial Results

Nov 27, 2024, 8:30 AM EST - 1 year ago

Prenetics Announces Third Quarter 2024 Financial Results


Prenetics Announces First Quarter 2024 Financial Results

Jun 18, 2024, 8:30 AM EDT - 2 years ago

Prenetics Announces First Quarter 2024 Financial Results


Prenetics Global Registration statement: Registration Filing

Feb 5, 2024, 7:00 AM EST - 2 years ago

Prenetics Global Registration statement: Registration Filing


Prenetics Global Registration statement: Registration Filing

Jan 17, 2024, 7:00 AM EST - 2 years ago

Prenetics Global Registration statement: Registration Filing


Prenetics Announces Third Quarter 2023 Financial Results

Nov 20, 2023, 6:00 AM EST - 2 years ago

Prenetics Announces Third Quarter 2023 Financial Results


Prenetics Global Limited Announces Reverse Stock Split

Nov 1, 2023, 6:00 AM EDT - 2 years ago

Prenetics Global Limited Announces Reverse Stock Split


Boss1239
Boss1239 Jun. 25 at 9:41 PM
$PRE not sure what to think
0 · Reply
ZacksSCR
ZacksSCR Jun. 23 at 8:58 PM
$PRE CEO Danny Yeung discusses Prenetics' transition from a COVID-era diagnostics business to a wellness brand, and management's view of the category's market opportunity in our latest CEO Chat: https://buff.ly/HV4PDZs
0 · Reply
Sidoti
Sidoti Jun. 23 at 11:32 AM
New research this week on @Prenetics $PRE #sidotiresearch Read note: http://dlvr.it/TT9cH2 #investing #smallcap #microcap
0 · Reply
ZacksSCR
ZacksSCR Jun. 10 at 3:12 PM
$PRE Continues to Post Rapid Growth https://buff.ly/VX7WdKG
0 · Reply
MarketBeat
MarketBeat May. 14 at 7:06 PM
https://marketbeat.com/a/8654885/ $PRE Prenetics Global Q1 Earnings Call Highlights
0 · Reply
ZacksSCR
ZacksSCR May. 14 at 4:42 PM
$PRE Continues Astounding Growth, While Expanding Product Line https://buff.ly/UD4qC7E
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 14 at 1:15 PM
$PRE Q1 '26 Earnings Results & Recap Prenetics raised its full-year 2026 IM8 revenue guidance to $190 million to $210 million, up from the prior range of $180 million to $200 million. Prenetics projects Q2 2026 revenue to be $46 million to $48 million.
0 · Reply
focafoca99
focafoca99 May. 14 at 12:24 PM
$PRE installed Brian J. Rosin as Chief Financial Officer of IM8.
0 · Reply
Sidoti
Sidoti May. 13 at 5:30 PM
New research today on @Prenetics $PRE #sidotiresearch Read note: http://dlvr.it/TSWppr #investing #smallcap #microcap
0 · Reply
focafoca99
focafoca99 May. 4 at 1:50 PM
$PRE outlined its complete Bitcoin treasury divestment, selling about 510 BTC.
0 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 12:25 AM
$PRE Share Price: $16.62 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $2.12 – $2.62 Target Zone: $3.77 – $4.60 Potential Upside: 67% ROI Time to Expiration: 203 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksSCR
ZacksSCR Apr. 17 at 10:30 PM
$PRE initiated at $30 price target. IM8 brand hit $120M ARR in 12 months. Company debt-free with $170M cash. Athlete partnerships structured as equity, not endorsement fees. https://youtu.be/IIfurXL7wtc
1 · Reply
ZacksSCR
ZacksSCR Apr. 8 at 3:27 PM
Initiating Coverage of Rapid-Growing $PRE https://buff.ly/216Ezbz
0 · Reply
focafoca99
focafoca99 Apr. 2 at 7:57 PM
$PRE Giannis Antetokounmpo is joining IM8 as a global partner and shareholder under a multi-year deal, giving the brand a much bigger athlete face.
0 · Reply
Sidoti
Sidoti Mar. 30 at 12:21 PM
New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap
0 · Reply
Sidoti
Sidoti Mar. 20 at 4:55 PM
Prenetics Global Limited ($PRE) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_1d-20z12RkKM5y8lzKf6Xw
0 · Reply
positiveguy
positiveguy Mar. 19 at 5:17 PM
$PRE PLEASE BUY IGNITON FROM GAIA . THEY HAVE NO CLUE.
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 2:46 PM
$PRE 10:17 on Mar. 16 2026 Lake Street Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $29 #tradeideas
0 · Reply
STACKD0E
STACKD0E Mar. 16 at 1:41 PM
$PRE 🙃✨
0 · Reply
rroycenyc
rroycenyc Mar. 10 at 3:40 PM
0 · Reply
topstockalerts
topstockalerts Mar. 6 at 6:43 PM
Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months, saying the move reflects management’s belief that the current stock price undervalues the business. During Feb. 23–27, executives purchased about $1.3 million in shares on the open market at an average price of around $17.11, including roughly $750,000 bought personally by CEO Danny Yeung. Combined with $1.45 million purchased after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. The company also completed several strategic divestitures in 2025 and early 2026. $PRE
0 · Reply
topstockalerts
topstockalerts Mar. 6 at 4:38 PM
Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months. The health sciences company said the move reflects management’s view that the current share price does not reflect the business’s underlying value. During Feb. 23–27, Prenetics executives bought about $1.3 million in shares on the open market at an average price of roughly $17.11, including about $750,000 purchased personally by CEO Danny Yeung. Combined with $1.45 million in purchases after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. $PRE
0 · Reply